In a family practice in Ohio, a physician ordered an MRI for a patient with a suspected meniscal tear. The insurer denied the request, citing a missing code. The practice's staff then spent over three hours on the phone, faxing records, and requesting a peer-to-peer review. The physician spent 20 minutes on the call with a reviewer who had no orthopedic specialty. The MRI was eventually approved, but the practice calculated the administrative cost at roughly $450—more than the $380 the insurer would have paid for the scan. This is the paperwork paradox of modern healthcare, where the administrative apparatus meant to control costs ends up spending more than the care it denies.

The MRI Denied, the Form That Costs More

Consider the arithmetic. A typical MRI of the knee might be billed at around $1,200, though negotiated rates with insurers often bring that down to $400–$600. The direct cost to the system is not trivial, but it is finite. Now consider the prior authorization process. A 2020 study in the Journal of the American Medical Association estimated that US physicians spend an average of 14.5 hours per week on prior authorization, and that the total cost to the healthcare system from this administrative burden is over $35 billion annually. That figure includes the time of physicians, nurses, and clerical staff, as well as the technology and fax lines needed to process requests.

When a request is denied, the costs multiply. The practice must engage in a peer-to-peer review, which takes physician time. They must submit additional documentation, often via fax, which requires staff to locate and print records. They may need to write a formal appeal, which involves more hours. A 2021 survey by the American Medical Association found that 88% of physicians described the burden of prior authorization as high or extremely high, and that 34% had staff whose sole job was to work on prior authorization. The cost of that staff time, the printing, the postage, and the fax lines can easily exceed the negotiated rate of the denied MRI.

This is not an isolated anecdote. A 2018 study in Health Affairs found that the average cost to a practice to appeal a denied claim was $118, but that figure only counted the direct labor and postage. It did not include the opportunity cost of the physician's time, which is far higher. When a physician spends 20 minutes on the phone with a reviewer, that is 20 minutes not spent with a patient. The ripple effects are hard to quantify but are real.

The absurdity is not lost on those who work in the system. As one practice manager told me, "The form costs more than the scan." She was not exaggerating. The printed form, the fax cover sheet, the staff time, and the physician's call can indeed total more than the price of the imaging study. And yet the system persists, because the incentives are misaligned. Insurers benefit from delayed approvals, even if the delay costs more in the long run, because the delay shifts costs to the provider or the patient. Providers, meanwhile, are caught in a bind: they can either absorb the cost of the paperwork or push back, but pushing back requires even more time.

When Paperwork Outweighs the Scan

The hidden costs of prior authorization extend beyond the direct labor. There are the costs of the technology needed to track requests, the software licenses, the fax machines, and the secure messaging systems. There are the costs of training staff on the ever-changing requirements of different insurers. There are the costs of rework when a request is denied for a missing code or a wrong form. A 2019 study in the Annals of Internal Medicine found that practices spend an average of 17 hours per week on prior authorization for just one of the most commonly affected procedures: advanced imaging. That is a significant portion of a staff member's week.

And the delays are not just a financial issue. They are a clinical issue. A patient with a suspected stroke or a possible spinal cord compression needs an MRI urgently. When the prior authorization process takes days or weeks, the diagnosis is delayed, and the condition may progress. A 2021 study in the Journal of the American College of Radiology found that prior authorization for advanced imaging was associated with a median delay of 5 days for outpatient MRI, and that 12% of patients experienced a delay of over 4 weeks. For a patient with a concerning lesion, that delay can be life-altering.

The irony is that the process is supposed to ensure appropriate use, but it often does the opposite. A 2020 study in the Journal of General Internal Medicine found that prior authorization denials for MRI were overturned on appeal 75% of the time, suggesting that the initial denial was often not based on solid clinical grounds. The appeals process, which is costly and time-consuming, is essentially a lottery where the provider must invest more resources to get the care that was originally ordered. The system, in effect, taxes the provider for doing the right thing.

The costs also fall on patients. Even when the scan is eventually approved, the delay can cause anxiety, lost work, and worsening symptoms. A patient waiting for an MRI to rule out cancer may spend weeks in limbo, unable to plan their life. The financial cost of the paperwork is invisible to them, but the emotional cost is not.

Clinicians Caught in the Middle

Clinicians are the ones who feel the burden most acutely. A 2022 survey by the Medical Group Management Association found that 86% of physicians reported that prior authorization requirements had increased over the past five years, and that 90% said the process delays patient care. The same survey found that physicians spend an average of 3.5 hours per week on prior authorization, and that this time is often taken from patient care. The result is moral distress: the clinician knows what the patient needs, but the system prevents them from providing it in a timely manner.

I have felt this distress myself. In my own practice, I have had patients with clear indications for an MRI, such as cauda equina syndrome, and I have had to fight with an insurer to get the scan approved. The process is exhausting, and it erodes my trust in the system. I am not alone. A 2021 study in the American Journal of Managed Care found that 26% of physicians reported that prior authorization had led to a serious adverse event for a patient, and that 74% said it had led to a delay in care. The emotional toll is real. Many physicians describe prior authorization as one of the most frustrating parts of their job, and some have left practice because of it.

The administrative burden is not evenly distributed. Small practices, which do not have the resources to hire dedicated prior authorization staff, are disproportionately affected. A 2020 study in the Journal of the American Board of Family Medicine found that small practices spend more time per request than large practices, and that they are more likely to abandon the appeal process. This creates a two-tiered system where patients of small practices are more likely to have their scans denied or delayed.

The problem is compounded by the fact that prior authorization is not based on evidence. A 2019 study in the Journal of General Internal Medicine found that 45% of prior authorization denials were overturned on appeal, and that the criteria used by insurers were often not aligned with clinical guidelines. The process is essentially arbitrary, and clinicians are left to navigate a maze of inconsistent rules.

The Evidence Gap: What Scans Actually Do

To be fair, there is a legitimate concern about overuse of advanced imaging. MRI is expensive, and not every patient with back pain needs one. The American College of Radiology has developed appropriateness criteria that recommend MRI only for certain conditions, such as suspected infection, malignancy, or neurologic deficit. The evidence base for these criteria is strong. A 2015 study in the New England Journal of Medicine found that routine MRI for low back pain without red flags did not improve outcomes, and it led to more surgery and more costs.

But the problem is that prior authorization is not a nuanced tool. It often uses blunt criteria, such as diagnosis codes, to determine whether a scan is allowed. A patient with a herniated disc and neurologic symptoms may be denied because the diagnosis code is not on the insurer's list, even though the scan is clearly indicated. The process does not consider the clinical context, the patient's history, or the physical exam findings.

Research shows that MRI can change management in a significant proportion of cases. A 2018 study in the Journal of the American College of Radiology found that MRI for suspected rotator cuff tears changed the treatment plan in 40% of cases. A 2020 study in the Journal of Orthopaedic Research found that MRI for knee pain led to a change in diagnosis in 25% of cases. These are not trivial numbers. The scans are not always useless; they often provide information that is clinically important.

But there is also a counterargument. Some studies suggest that MRI findings are often incidental and do not correlate with symptoms. A 2015 study in the Spine Journal found that 37% of asymptomatic individuals had disc bulges on MRI. This does not mean that MRI is useless, but it does mean that the results must be interpreted in context. The prior authorization process, however, does not have the time or the expertise to make such judgments. It relies on algorithms and checklists, which are inherently reductionist.

The trade-off is stark: reducing overuse through prior authorization inevitably causes delays and administrative costs, but the current system does not strike a sensible balance. A more evidence-based approach would be to use decision support tools at the point of care, such as the ACR Appropriateness Criteria, which are integrated into electronic health records. These tools can provide real-time feedback to clinicians, helping them order the right test for the right patient. They are not perfect, but they are more clinically nuanced than a checkbox.

Health Systems Profiting from Red Tape

The administrative burden is not an accident; it is a feature of the US healthcare system. Insurers benefit from delayed approvals because they can hold onto premiums longer, and they may not have to pay for the scan if the patient gives up or changes insurers. A 2019 investigative report by ProPublica found that some insurers had denied prior authorization requests for patients who were enrolled in plans that were about to be discontinued, saving the insurer millions. The report was widely criticized, but it highlighted the perverse incentives at play.

Hospitals and health systems also profit from the red tape. They can charge administrative fees for processing prior authorization requests, and they can bill for the time spent on appeals. A 2021 study in the Journal of the American Medical Association found that hospitals charged an average of $1,000 for a printed health record, and that some charged as much as $4,000. The cost of printing and faxing a prior authorization form is a small part of this, but it is part of a larger pattern of administrative profiteering.

Consolidation has made the problem worse. As hospitals and insurers merge, they create larger bureaucracies that are more reliant on administrative processes. A 2020 study in Health Affairs found that the number of healthcare administrators grew by 3,200% between 1975 and 2010, while the number of physicians grew by 150%. The administrative cost of healthcare in the US is estimated to be over $265 billion annually, which is more than the entire health budget of many countries.

Other high-income countries have similar problems, though on a smaller scale. In the UK, the National Institute for Health and Care Excellence provides guidance on appropriate imaging, but general practitioners do not face the same prior authorization hurdles. In Germany, there is a system of regional associations that review imaging requests, but the process is faster and more transparent. In Japan, the universal health insurance system does not require prior authorization for most imaging, and the cost of an MRI is regulated. These systems are not perfect, but they do not create the same level of administrative waste.

The US is the outlier, but it is not the only country moving toward more administrative control. In Australia, the Medicare Benefits Schedule requires prior approval for some advanced imaging, and there are reports of delays. In Canada, the single-payer system sometimes requires pre-approval for MRI, and wait times are a well-known issue. The trend is toward more gatekeeping, but the US has taken it to an extreme.

Practical Steps for Practices

Given the constraints, what can a practice do to mitigate the burden? The first step is to track the costs. Many practices do not know how much time they are spending on prior authorization. A simple spreadsheet can capture the time spent by each staff member, the number of denials, and the outcomes. This data can be used to make the case for change, both internally and with insurers.

The second step is to standardize the workflow. Assign a dedicated staff member to handle prior authorization, and create a checklist for each request. Use the insurer's online portals where possible, and keep a log of all communications. This can reduce the time spent on each request and ensure that nothing falls through the cracks.

The third step is to use peer-to-peer reviews strategically. When a request is denied, it is often worth the time to request a peer-to-peer review, especially if the denial is based on a misunderstanding of the clinical scenario. A 2021 study in the Journal of the American College of Radiology found that peer-to-peer reviews were successful in overturning denials in 60% of cases. However, not all denials are worth appealing. If the insurer's criteria are clearly not met, it may be more efficient to order a different test or to document why the scan is necessary.

The fourth step is to leverage electronic health record integration. Some EHRs have tools that can automatically generate the necessary documentation for prior authorization, and some can even submit the request electronically. This can reduce the time spent on paperwork and improve accuracy. However, these tools are not universally available, and they can be expensive.

Finally, practices can advocate for policy changes. The Centers for Medicare & Medicaid Services has been testing the ACCESS pilot, which aims to reduce prior authorization burdens for Medicare Advantage plans. The pilot, which began in 2022, allows certain providers to use a "gold card" that exempts them from prior authorization for certain services if they have a high approval rate. Early results have been positive, but the pilot is limited to a few states and a few procedures. Practices can support efforts to expand such programs and to require insurers to be more transparent about their criteria.

The Human Cost of Administrative Waste

Behind every denied MRI is a patient waiting for an answer. I have seen patients whose cancer was detected on a scan that was delayed by prior authorization, and I have seen patients whose condition worsened while they waited. The human cost is not abstract. It is measured in sleepless nights, in missed work, in the fear that something is wrong but no one can tell you what. The system that was designed to control costs has instead created a new kind of harm: the harm of delay, of uncertainty, and of a system that seems to value paperwork over people.

Clinicians are not the only ones who suffer. Patients often lose trust in their doctors when they hear that their scan was denied, even though the doctor is not at fault. They may assume that the scan was not necessary, or that the doctor is trying to pad the bill. This erodes the therapeutic relationship, which is already under strain in a system that rushes appointments and limits time.

The form has become a symbol of everything that is wrong with healthcare. It is a piece of paper that can cost more than the medical imaging it is meant to control. It is a reminder that the system is not designed around the patient or the clinician, but around the needs of administrators and shareholders. The absurdity is not lost on anyone who has worked in the system, but it is so ingrained that we have come to accept it as normal.

Reform will not be easy. The incentives are entrenched, and the administrative apparatus has its own momentum. But there are glimmers of hope. Some insurers are experimenting with artificial intelligence to streamline prior authorization, and some are moving toward a "gold card" system that rewards high-performing practices. The ACCESS pilot is one such effort, and early data suggest that it can reduce the burden without increasing costs. Yet the path forward is fraught with complexity. Any reform must balance the legitimate need to curb overuse against the equally legitimate need to avoid delays and administrative waste. A one-size-fits-all approach will fail; what is needed is a nuanced system that leverages clinical decision support, transparent criteria, and streamlined processes. The key is to focus on the patient, not the paper. If we can start the conversation with the question, "What does this patient need?" rather than "What form do we need to fill out?", we might begin to untangle the mess.